Kit ELISA sandwich RARRES2/TIG2 (human): quantitative determination of Hu RARRES2 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu RARRES2.
Accession number
Q99969
Dose range
0.51-50 ng/ml
Sensitivity of the dosage
0.5 ng
Calibration range
0.5 ng/ml to 50 ng/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA sandwich RARRES2/TIG2 (human): quantitative determination of Hu RARRES2 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu RARRES2.
Kit ELISA sandwich RARRES2/TIG2 (human): quantitative determination of Hu RARRES2 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu RARRES2.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
Retinoids act by ligand-related transcription factors, retinoid X receptors (RXR) and retinoic acid receptors (RAR). Tazarotene-induced (TIG) gene proteins, also referred to as retinoic acid receptor proteins or RAR reactive proteins, may be bound to or secreted by the membrane. TIGs act as tumour suppressor genes in human cancers and are strongly expressed in the skin, hair follicles and endothelial cells as well as in the pancreas, spleen and intestine. TIGs are activated by tazarotene and have been involved as growth regulators that mediate the growth suppressor effects of retinoids. TIG1 is a single-pass type II membrane protein activated by tazarotene and RAR proteins. It belongs to the protein family of protease inhibitor I47 (latexine). TIG2 is a secreted protein that is mainly expressed in the epidermis, hair follicles and endothelial cells. TIG2 is inhibited in psoriatic lesions and activated by tazarotene in skin grafts and in the epidermis of psoriatic lesions. TIG3 is widely expressed in most tissues, but is not detected in the heart, testicles or brain. TIG3, activated by tazarotene, belongs to the H-rev107 family of proteins. TIG3 acts as a growth regulator and is important for mediating the growth suppressor effects of retinoids.